Ferroptosis in renal fibrosis: a mini-review

References

• Foreman KJ, Marquez N, Dolgert A, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet. 2018;392(10159):2052–2090. doi: 10.1016/S0140-6736(18)31694-5.
   PubMed Web of Science ®Google Scholar
• Webster AC, Nagler EV, Morton RL, et al. Chronic kidney disease. Lancet. 2017;389(10075):1238–1252. doi: 10.1016/S0140-6736(16)32064-5.
   PubMed Web of Science ®Google Scholar
• Humphreys BD. Mechanisms of renal fibrosis. Annu Rev Physiol. 2018;80(1):309–326. doi: 10.1146/annurev-physiol-022516-034227.
   PubMedGoogle Scholar
• Ruiz-Ortega M, Rayego-Mateos S, Lamas S, et al. Targeting the progression of chronic kidney disease. Nat Rev Nephrol. 2020;16(5):269–288. doi: 10.1038/s41581-019-0248-y.
   PubMed Web of Science ®Google Scholar
• Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–1072. doi: 10.1016/j.cell.2012.03.042.
   PubMed Web of Science ®Google Scholar
• Li J, Cao F, Yin HL, et al. Ferroptosis: past, present and future. Cell Death Dis. 2020;11(2):88. doi: 10.1038/s41419-020-2298-2.
   PubMed Web of Science ®Google Scholar
• Wang J, Wang Y, Liu Y, et al. Ferroptosis, a new target for treatment of renal injury and fibrosis in a 5/6 nephrectomy-induced CKD rat model. Cell Death Discov. 2022;8(1):127. doi: 10.1038/s41420-022-00931-8.
   PubMed Web of Science ®Google Scholar
• Zhou L, Xue X, Hou Q, et al. Targeting ferroptosis attenuates interstitial inflammation and kidney fibrosis. Kidney Dis (Basel). 2022;8(1):57–71. doi: 10.1159/000517723.
   PubMed Web of Science ®Google Scholar
• Tonnus W, Meyer C, Steinebach C, et al. Dysfunction of the key ferroptosis-surveilling systems hypersensitizes mice to tubular necrosis during acute kidney injury. Nat Commun. 2021;12(1):4402. doi: 10.1038/s41467-021-24712-6.
   PubMed Web of Science ®Google Scholar
• Linkermann A, Skouta R, Himmerkus N, et al. Synchronized renal tubular cell death involves ferroptosis. Proc Natl Acad Sci USA. 2014;111(47):16836–16841. doi: 10.1073/pnas.1415518111.
   PubMed Web of Science ®Google Scholar
• Wang X, Zheng X, Zhang J, et al. Physiological functions of ferroportin in the regulation of renal iron recycling and ischemic acute kidney injury. Am J Physiol Renal Physiol. 2018;315(4):F1042–F1057. doi: 10.1152/ajprenal.00072.2018.
   PubMed Web of Science ®Google Scholar
• McCullough K, Bolisetty S. Iron homeostasis and ferritin in Sepsis-Associated kidney injury. Nephron. 2020;144(12):616–620. doi: 10.1159/000508857.
   PubMed Web of Science ®Google Scholar
• Hayes W. Measurement of iron status in chronic kidney disease. Pediatr Nephrol. 2019;34(4):605–613. doi: 10.1007/s00467-018-3955-x.
   PubMed Web of Science ®Google Scholar
• Dolma S, Lessnick SL, Hahn WC, et al. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell. 2003;3(3):285–296. doi: 10.1016/s1535-6108(03)00050-3.
   PubMed Web of Science ®Google Scholar
• Yagoda N, von Rechenberg M, Zaganjor E, et al. RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature. 2007;447(7146):864–868. doi: 10.1038/nature05859.
   PubMed Web of Science ®Google Scholar
• Yang WS, Stockwell BR. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem Biol. 2008;15(3):234–245. doi: 10.1016/j.chembiol.2008.02.010.
   PubMedGoogle Scholar
• Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266–282. doi: 10.1038/s41580-020-00324-8.
   PubMed Web of Science ®Google Scholar
• Miyake S, Murai S, Kakuta S, et al. Identification of the hallmarks of necroptosis and ferroptosis by transmission electron microscopy. Biochem Biophys Res Commun. 2020;527(3):839–844. doi: 10.1016/j.bbrc.2020.04.127.
   PubMed Web of Science ®Google Scholar
• Sanz AB, Sanchez-Niño MD, Ramos AM, et al. Regulated cell death pathways in kidney disease. Nat Rev Nephrol. 2023;19(5):281–299. doi: 10.1038/s41581-023-00694-0.
   PubMed Web of Science ®Google Scholar
• Miller DR, Thorburn A. Autophagy and organelle homeostasis in cancer. Dev Cell. 2021;56(7):906–918. doi: 10.1016/j.devcel.2021.02.010.
   PubMed Web of Science ®Google Scholar
• Tan S, Chen S. The mechanism and effect of autophagy, apoptosis, and pyroptosis on the progression of silicosis. Int J Mol Sci. 2021;22(15):8110. doi: 10.3390/ijms22158110.
   PubMed Web of Science ®Google Scholar
• Friedmann Angeli JP, Schneider M, Proneth B, et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol. 2014;16(12):1180–1191. doi: 10.1038/ncb3064.
   PubMed Web of Science ®Google Scholar
• Chen X, Kang R, Kroemer G, et al. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol. 2021;18(5):280–296. doi: 10.1038/s41571-020-00462-0.
   PubMed Web of Science ®Google Scholar
• Sato H, Tamba M, Ishii T, et al. Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins*. J Biol Chem. 1999;274(17):11455–11458. doi: 10.1074/jbc.274.17.11455.
   PubMed Web of Science ®Google Scholar
• Zhu J, Berisa M, Schwörer S, et al. Transsulfuration activity can support cell growth upon extracellular cysteine limitation. Cell Metab. 2019;30(5):865–876.e5. doi: 10.1016/j.cmet.2019.09.009.
   PubMed Web of Science ®Google Scholar
• Lewerenz J, Hewett SJ, Huang Y, et al. The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal. 2013;18(5):522–555. doi: 10.1089/ars.2011.4391.
   PubMed Web of Science ®Google Scholar
• Wang L, Liu Y, Du T, et al. ATF3 promotes erastin-induced ferroptosis by suppressing system Xc. Cell Death Differ. 2020;27(2):662–675. – doi: 10.1038/s41418-019-0380-z.
   PubMed Web of Science ®Google Scholar
• Sun Y, Zheng Y, Wang C, et al. Glutathione depletion induces ferroptosis, autophagy, and premature cell senescence in retinal pigment epithelial cells. Cell Death Dis. 2018;9(7):753. doi: 10.1038/s41419-018-0794-4.
   PubMed Web of Science ®Google Scholar
• Jiang L, Hickman JH, Wang S-J, et al. Dynamic roles of p53-mediated metabolic activities in ROS-induced stress responses. Cell Cycle. 2015;14(18):2881–2885. doi: 10.1080/15384101.2015.1068479.
   PubMed Web of Science ®Google Scholar
• Wang S, Luo J, Zhang Z, et al. Iron and magnetic: new research direction of the ferroptosis-based cancer therapy. Am J Cancer Res. 2018;8:1933–1946.
   PubMed Web of Science ®Google Scholar
• Maiorino M, Conrad M, Ursini F. GPx4, lipid peroxidation, and cell death: discoveries, rediscoveries, and open issues. Antioxid Redox Signal. 2018;29(1):61–74. doi: 10.1089/ars.2017.7115.
   PubMed Web of Science ®Google Scholar
• Stockwell BR, Jiang X, Gu W. Emerging mechanisms and disease relevance of ferroptosis. Trends Cell Biol. 2020;30(6):478–490. doi: 10.1016/j.tcb.2020.02.009.
   PubMed Web of Science ®Google Scholar
• Leaf DE, Rajapurkar M, Lele SS, et al. Iron, hepcidin, and death in human AKI. J Am Soc Nephrol. 2019;30(3):493–504. doi: 10.1681/ASN.2018100979.
   PubMed Web of Science ®Google Scholar
• Kang H, Han M, Xue J, et al. Renal clearable nanochelators for iron overload therapy. Nat Commun. 2019;10(1):5134. doi: 10.1038/s41467-019-13143-z.
   PubMedGoogle Scholar
• Ikeda Y, Hamano H, Horinouchi Y, et al. Role of ferroptosis in cisplatin-induced acute nephrotoxicity in mice. J Trace Elem Med Biol. 2021;67:126798. doi: 10.1016/j.jtemb.2021.126798.
   PubMed Web of Science ®Google Scholar
• Sousa L, Pessoa MTC, Costa TGF, et al. Iron overload impact on P-ATPases. Ann Hematol. 2018;97(3):377–385. doi: 10.1007/s00277-017-3222-4.
   PubMed Web of Science ®Google Scholar
• Baba Y, Higa JK, Shimada BK, et al. Protective effects of the mechanistic target of rapamycin against excess iron and ferroptosis in cardiomyocytes. Am J Physiol Heart Circ Physiol. 2018;314(3):H659–H668. doi: 10.1152/ajpheart.00452.2017.
   PubMed Web of Science ®Google Scholar
• Mehta KJ, Farnaud SJ, Sharp PA. Iron and liver fibrosis: mechanistic and clinical aspects. World J Gastroenterol. 2019;25(5):521–538. doi: 10.3748/wjg.v25.i5.521.
   PubMed Web of Science ®Google Scholar
• Wang C-Y, Babitt JL. Liver iron sensing and body iron homeostasis. Blood. 2019;133(1):18–29. doi: 10.1182/blood-2018-06-815894.
   PubMed Web of Science ®Google Scholar
• Antonelli A, Pacifico S, Sfara C, et al. Ferucarbotran-loaded red blood cells as long circulating MRI contrast agents: first in vivo results in mice. Nanomedicine. 2018;13(7):675–687. doi: 10.2217/nnm-2017-0339.
   PubMed Web of Science ®Google Scholar
• McFarlane SI, Chen SC, Whaley-Connell AT, et al. Prevalence and associations of anemia of CKD: kidney early evaluation program (KEEP) and national health and nutrition examination survey (NHANES) 1999-2004. Am J Kidney Dis. 2008;51(4 Suppl 2):S46–S55. doi: 10.1053/j.ajkd.2007.12.019.
   PubMed Web of Science ®Google Scholar
• Takasawa K, Takaeda C, Wada T, et al. Optimal serum ferritin levels for iron deficiency anemia during oral iron therapy (OIT) in japanese hemodialysis patients with minor inflammation and benefit of intravenous iron therapy for OIT-Nonresponders. Nutrients. 2018;10(4):428. doi: 10.3390/nu10040428.
   PubMed Web of Science ®Google Scholar
• Scindia Y, Leeds J, Swaminathan S. Iron homeostasis in healthy kidney and its role in acute kidney injury. Semin Nephrol. 2019;39:76–84. doi: 10.1016/j.semnephrol.2018.10.006.
   PubMed Web of Science ®Google Scholar
• Doll S, Conrad M. Iron and ferroptosis: a still ill-defined liaison. IUBMB Life. 2017;69(6):423–434. doi: 10.1002/iub.1616.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Zak O, Aisen P, et al. Structure of the human transferrin receptor-transferrin complex. Cell. 2004;116(4):565–576. doi: 10.1016/S0092-8674(04)00130-8.
   PubMed Web of Science ®Google Scholar
• Tang D, Chen X, Kang R, et al. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31(2):107–125. doi: 10.1038/s41422-020-00441-1.
   PubMed Web of Science ®Google Scholar
• Gunshin H, Mackenzie B, Berger UV, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature. 1997;388(6641):482–488. doi: 10.1038/41343.
   PubMed Web of Science ®Google Scholar
• Chandrapalan T, Kwong RW. Influence of dietary iron exposure on trace metal homeostasis and expression of metal transporters during development in zebrafish*. Environ Pollut. 2020;261:114159. doi: 10.1016/j.envpol.2020.114159.
   PubMed Web of Science ®Google Scholar
• Feng H, Stockwell BR. Unsolved mysteries: how does lipid peroxidation cause ferroptosis? PLoS Biol. 2018;16(5):e2006203. doi: 10.1371/journal.pbio.2006203.
   PubMed Web of Science ®Google Scholar
• Pope LE, Dixon SJ. Regulation of ferroptosis by lipid metabolism. Trends Cell Biol. 2023;33(12):1077–1087. doi: 10.1016/j.tcb.2023.05.003.
   PubMed Web of Science ®Google Scholar
• Zou Y, Li H, Graham ET, et al. Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis. Nat Chem Biol. 2020;16(3):302–309. doi: 10.1038/s41589-020-0472-6.
   PubMed Web of Science ®Google Scholar
• Yan B, Ai Y, Sun Q, et al. Membrane damage during ferroptosis is caused by oxidation of phospholipids catalyzed by the oxidoreductases POR and CYB5R1. Mol Cell. 2021;81(2):355–369.e10. doi: 10.1016/j.molcel.2020.11.024.
   PubMed Web of Science ®Google Scholar
• Tuo QZ, Lei P, Jackman KA, et al. Tau-mediated iron export prevents ferroptotic damage after ischemic stroke. Mol Psychiatry. 2017;22(11):1520–1530. doi: 10.1038/mp.2017.171.
   PubMed Web of Science ®Google Scholar
• Cheng J, Fan YQ, Liu BH, et al. ACSL4 suppresses glioma cells proliferation via activating ferroptosis. Oncol Rep. 2020;43(1):147–158. doi: 10.3892/or.2019.7419.
   PubMed Web of Science ®Google Scholar
• Kagan VE, Mao G, Qu F, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol. 2017;13(1):81–90. doi: 10.1038/nchembio.2238.
   PubMed Web of Science ®Google Scholar
• Gnanapradeepan K, Basu S, Barnoud T, et al. The p53 tumor suppressor in the control of metabolism and ferroptosis. Front Endocrinol (Lausanne). 2018;9:124. doi: 10.3389/fendo.2018.00124.
   PubMed Web of Science ®Google Scholar
• Doll S, Freitas FP, Shah R, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575(7784):693–698. doi: 10.1038/s41586-019-1707-0.
   PubMed Web of Science ®Google Scholar
• Yi J, Zhu J, Wu J, et al. Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis. Proc Natl Acad Sci USA. 2020;117(49):31189–31197. doi: 10.1073/pnas.2017152117.
   PubMed Web of Science ®Google Scholar
• Sun Y, He L, Wang T, et al. Activation of p62-Keap1-Nrf2 pathway protects 6-Hydroxydopamine-Induced ferroptosis in dopaminergic cells. Mol Neurobiol. 2020;57(11):4628–4641. doi: 10.1007/s12035-020-02049-3.
   PubMed Web of Science ®Google Scholar
• Zhang L, Chen F, Dong J, et al. HDAC3 aberration-incurred GPX4 suppression drives renal ferroptosis and AKI-CKD progression. Redox Biol. 2023;68:102939. doi: 10.1016/j.redox.2023.102939.
   PubMed Web of Science ®Google Scholar
• Tbahriti HF, Kaddous A, Bouchenak M, et al. Effect of different stages of chronic kidney disease and renal replacement therapies on oxidant-antioxidant balance in uremic patients. Biochem Res Int. 2013;2013:358985–358986. doi: 10.1155/2013/358985.
   PubMedGoogle Scholar
• Nakanishi T, Kuragano T, Nanami M, et al. Misdistribution of iron and oxidative stress in chronic kidney disease. Free Radic Biol Med. 2019;133:248–253. doi: 10.1016/j.freeradbiomed.2018.06.025.
   PubMed Web of Science ®Google Scholar
• Soulage CO, Pelletier CC, Florens N, et al. Two toxic lipid aldehydes, 4-hydroxy-2-hexenal (4-HHE) and 4-hydroxy-2-nonenal (4-HNE), accumulate in patients with chronic kidney disease. Toxins (Basel). 2020;12(9):567. doi: 10.3390/toxins12090567.
   PubMed Web of Science ®Google Scholar
• Staniek H, Wójciak RW. The combined effects of iron excess in the diet and chromium(III) supplementation on the iron and chromium status in female rats. Biol Trace Elem Res. 2018;184(2):398–408. doi: 10.1007/s12011-017-1203-z.
   PubMed Web of Science ®Google Scholar
• Nankivell BJ, Chen J, Boadle RA, et al. The role of tubular iron accumulation in the remnant kidney. J Am Soc Nephrol. 1994;4(8):1598–1607. doi: 10.1681/ASN.V481598.
   PubMed Web of Science ®Google Scholar
• van Raaij S, van Swelm R, Bouman K, et al. Tubular iron deposition and iron handling proteins in human healthy kidney and chronic kidney disease. Sci Rep. 2018;8(1):9353. doi: 10.1038/s41598-018-27107-8.
   PubMedGoogle Scholar
• Li S, Zheng L, Zhang J, et al. Inhibition of ferroptosis by up-regulating Nrf2 delayed the progression of diabetic nephropathy. Free Radic Biol Med. 2021;162:435–449. doi: 10.1016/j.freeradbiomed.2020.10.323.
   PubMed Web of Science ®Google Scholar
• Shi Y, Shi X, Zhao M, et al. Ferroptosis is involved in focal segmental glomerulosclerosis in rats. Sci Rep. 2023;13(1):22250. doi: 10.1038/s41598-023-49697-8.
   PubMed Web of Science ®Google Scholar
• Naito Y, Fujii A, Sawada H, et al. Association between renal iron accumulation and renal interstitial fibrosis in a rat model of chronic kidney disease. Hypertens Res. 2015;38(7):463–470. doi: 10.1038/hr.2015.14.
   PubMed Web of Science ®Google Scholar
• Kim S, Kang SW, Joo J, et al. Characterization of ferroptosis in kidney tubular cell death under diabetic conditions. Cell Death Dis. 2021;12(2):160. doi: 10.1038/s41419-021-03452-x.
   PubMed Web of Science ®Google Scholar
• Zhang X, Li LX, Ding H, et al. Ferroptosis promotes cyst growth in autosomal dominant polycystic kidney disease mouse models. J Am Soc Nephrol. 2021;32(11):2759–2776. doi: 10.1681/ASN.2021040460.
   PubMed Web of Science ®Google Scholar
• Huang LL, Liao XH, Sun H, et al. Augmenter of liver regeneration protects the kidney from ischaemia-reperfusion injury in ferroptosis. J Cell Mol Med. 2019;23(6):4153–4164. doi: 10.1111/jcmm.14302.
   PubMed Web of Science ®Google Scholar
• Jin J, Gong J, Zhao L, et al. Inhibition of high mobility group box 1 (HMGB1) attenuates podocyte apoptosis and epithelial-mesenchymal transition by regulating autophagy flux. J Diabetes. 2019;11(10):826–836. doi: 10.1111/1753-0407.12914.
   PubMed Web of Science ®Google Scholar
• Wu Y, Zhao Y, Yang HZ, et al. HMGB1 regulates ferroptosis through Nrf2 pathway in mesangial cells in response to high glucose. Biosci Rep. 2021;41(2):BSR20202924. doi: 10.1042/BSR20202924.
   PubMed Web of Science ®Google Scholar
• Zhang D, Meyron-Holtz E, Rouault TA. Renal iron metabolism: transferrin iron delivery and the role of iron regulatory proteins. J Am Soc Nephrol. 2007;18(2):401–406. doi: 10.1681/ASN.2006080908.
   PubMed Web of Science ®Google Scholar
• Chen L, Yang J, Zhao SJ, et al. Atractylodis rhizoma water extract attenuates fructose-induced glomerular injury in rats through anti-oxidation to inhibit TRPC6/p-CaMK4 signaling. Phytomedicine. 2021;91:153643. doi: 10.1016/j.phymed.2021.153643.
   PubMed Web of Science ®Google Scholar
• Oudot C, Lajoix AD, Jover B, et al. Dietary sodium restriction prevents kidney damage in high fructose-fed rats. Kidney Int. 2013;83(4):674–683. doi: 10.1038/ki.2012.478.
   PubMed Web of Science ®Google Scholar
• Wu WY, Wang ZX, Li TS, et al. SSBP1 drives high fructose-induced glomerular podocyte ferroptosis via activating DNA-PK/p53 pathway. Redox Biol. 2022;52:102303. doi: 10.1016/j.redox.2022.102303.
   PubMed Web of Science ®Google Scholar
• Balzer MS, Doke T, Yang YW, et al. Single-cell analysis highlights differences in druggable pathways underlying adaptive or fibrotic kidney regeneration. Nat Commun. 2022;13(1):4018. doi: 10.1038/s41467-022-31772-9.
   PubMed Web of Science ®Google Scholar
• Weiss A, Spektor L, A. Cohen L, et al. Orchestrated regulation of iron trafficking proteins in the kidney during iron overload facilitates systemic iron retention. PLoS One. 2018;13(10):e0204471. doi: 10.1371/journal.pone.0204471.
   PubMed Web of Science ®Google Scholar
• Nielsen R, Christensen EI, Birn H. Megalin and cubilin in proximal tubule protein reabsorption: from experimental models to human disease. Kidney Int. 2016;89(1):58–67. doi: 10.1016/j.kint.2015.11.007.
   PubMed Web of Science ®Google Scholar
• Tajima S, Tsuchiya K, Horinouchi Y, et al. Effect of angiotensin II on iron-transporting protein expression and subsequent intracellular labile iron concentration in human glomerular endothelial cells. Hypertens Res. 2010;33(7):713–721. doi: 10.1038/hr.2010.63.
   PubMed Web of Science ®Google Scholar
• Cheng HT, Yen CJ, Chang CC, et al. Ferritin heavy chain mediates the protective effect of heme oxygenase-1 against oxidative stress. Biochim Biophys Acta. 2015;1850(12):2506–2517. doi: 10.1016/j.bbagen.2015.09.018.
   PubMed Web of Science ®Google Scholar
• Zhang B, Chen X, Ru F, et al. Liproxstatin-1 attenuates unilateral ureteral obstruction-induced renal fibrosis by inhibiting renal tubular epithelial cells ferroptosis. Cell Death Dis. 2021;12(9):843. doi: 10.1038/s41419-021-04137-1.
   PubMed Web of Science ®Google Scholar
• Zhou J, Xiao C, Zheng S, et al. MicroRNA-214-3p aggravates ferroptosis by targeting GPX4 in cisplatin-induced acute kidney injury. Cell Stress Chaperones. 2022;27(4):325–336. doi: 10.1007/s12192-022-01271-3.
   PubMed Web of Science ®Google Scholar
• He X, Yang L, Wang M, et al. Targeting ferroptosis attenuates podocytes injury and delays tubulointerstitial fibrosis in focal segmental glomerulosclerosis. Biochem Biophys Res Commun. 2023;678:11–16. doi: 10.1016/j.bbrc.2023.08.029.
   PubMed Web of Science ®Google Scholar
• Ikeda Y, Ozono I, Tajima S, et al. Iron chelation by deferoxamine prevents renal interstitial fibrosis in mice with unilateral ureteral obstruction. PLoS One. 2014;9(2):e89355. doi: 10.1371/journal.pone.0089355.
   PubMed Web of Science ®Google Scholar
• Smythies JA, Sun M, Masson N, et al. Inherent DNA-binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin. EMBO Rep. 2019;20(1):e46401. doi: 10.15252/embr.201846401.
   PubMed Web of Science ®Google Scholar
• Li X, Zou Y, Xing J, et al. Pretreatment with roxadustat (FG-4592) attenuates folic acid-induced kidney injury through antiferroptosis via akt/GSK-3β/Nrf2 pathway. Oxid Med Cell Longev. 2020;2020:6286984. doi: 10.1155/2020/6286984.
   PubMed Web of Science ®Google Scholar